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Abstract 
Background   
Postnatal depression (PND) is common, affects the health of the mother, the development of 
the infant and places a large financial burden on services.  Genetic and epigenetic biomarkers 
for PND could potentially improve the accuracy of current antenatal screening approaches. 
The aim of this systematic review is to report on the evidence for an association between 
genetic or epigenetic factors and postnatal depression. 
 
Method 
A systematic search of five databases (Medline, EMBASE, PILOT, PsychINFO and 
SCOPUS) was carried out using the following (MeSh) terms and keywords:  postpartum, 
depression, postnatal depression, genetics, genetic polymorphisms and epigenetics.  Inclusion 
criteria were applied and quality of studies was assessed using guidelines from the HuGE 
Review Handbook (Little & Higgins 2006). 
 
Results 
Following removal of duplicate articles, 543 remained; of these 37 met the inclusion criteria.  
Positive associations have been reported between PND and polymorphisms in the HMNC1, 
COMT, MAOT, PRKCB, ESR1, SLC6A4 genes in the presence of stressful life events, the 
BDNF gene when the postnatal period occurs during autumn and winter months and the OXT 
and OXTR genes in the presence of childhood adversity experienced by the mother.  
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Epigenetic interactions with genotype, estrogen, and childhood adversity were identified that 
are predictive of PND.  
 
Limitations  
The number of studies investigating some of the markers was small and grey literature was 
not included. 
 
Conclusion   
This review highlights the importance of examining the interaction between epigenetic, 
genetic, hormonal and environmental factors in order to fully understand the risk factors for 
PND and to improve the accuracy of current antenatal and early postnatal screening 
procedures.  Women susceptible to PND appear to have heightened epigenetic sensitivity to 
the physiological changes of childbirth or to environmental factors conferred by genotype.   
 
 
Key Words: genetic polymorphism, epigenetic, depression, postpartum depression  
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1. Introduction   
The World Health Organisation estimates that 10-15% of women in industrialised countries 
and 20-40% of women in developing countries experience depression during pregnancy or 
postnatally (WHO 2009).  Outcomes for mothers and infants can be grave with poor mental 
health consistently identified as a major causal factor in maternal morbidities during the 
perinatal period (CEMACH 2007, MBRACE 2014).  The symptoms that mothers’ experience 
can impact upon the quality of the care they provide to their babies.  Critically, the synchrony 
of maternal-infant interaction is interrupted affecting infant development, with consequences 
that can be life-long (Apter-Levy et al, 2013).  
 
Women can become depressed at any time during pregnancy or motherhood, however in this 
review, we focus on depression that is of a postnatal onset and use the term postnatal 
depression (PND) to refer to depression that has a postnatal onset.   An estimated 50% of 
women with PND go undiagnosed (Beck 2006).  If detection rates are to be improved valid 
and reliable methods of identifying women during pregnancy who have an elevated risk of 
PND are extremely important.  
Depression is a chronic disorder of low mood that is understood to result from an interaction 
between environmental and hereditary factors (Uher 2008) and research has begun to focus 
on identifying the genetic factors that contribute to such a common mental illness.  Genetic 
polymorphisms, variants of a particular DNA sequence, and epigenetic modifications which 
make genes available or unavailable for transcription (Syzf et al, 2000) can alter gene 
expression, and may be a source of differences in physical and psychological processes (El-
Ilbiary et al, 2010). If biomarkers, detectable in antenatal blood, could be used to predict 
PND, this could enhance current approaches to identifying women at risk including 
psychosocial history and screening for antenatal depression (NICE 2014).  
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Three literature reviews have previously reported on associations between genetic variants 
and childbirth related depression.  Figueiredo et al (2015) reported on perinatal depression 
rather than PND.  In 2015, Couto et al, summarised the results from studies published prior to 
April 2014, linking genetic susceptibility to PND. The most recent review, by McEvoy et al 
(2017), was a qualitative review summarising the evidence for genetic associations with 
premenstrual dysphoric disorder and postnatal depression. Advancements in genetic research 
in PND have been rapid over the last few years and there has been no systematic review of 
the literature on epigenetic biomarkers that may confer increased risk of developing PND. 
The overall aim of this systematic review, therefore, was to examine the current evidence for 
an association between genetic or epigenetic markers and postnatal depression.  
 
2. Methods 
Data sources and search strategy 
The widely-accepted ‘Preferred Reporting Items for Systematic Reviews and Meta-Analyses’ 
(PRISMA) (Moher 2009) guidelines were used to perform a systematic search of the literature. 
In order to address the question ‘Is there an association between genetic or epigenetic markers 
and postnatal depression?’ Medical Subject Headings (MeSH) and text words (postpartum, 
postnatal, depression, postnatal depression, genetics, genetic polymorphisms and epigenetics) 
were used to search five online databases (EMBASE, Medline, SCOPUS, PILOT and 
PsychInfo) to identify primary research studies. Dates were not restricted to make the search 
as comprehensive as possible.  The keywords and MeSH terms were tested in Medline and then 
refined for the other databases. The reference lists of identified studies were also searched by 
hand for any further relevant papers. 
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Inclusion Criteria  
To be included in the review the papers had to meet the following criteria: 1. Reporting 
original research; 2. genetic polymorphisms or epigenetic markers were investigated; 3. either 
depression or elevated symptoms of depression were measured; 4. human participants were 
studied. Language was not restricted.  
 
Quality appraisal of studies 
To reduce bias in conducting this review and to assist in the interpretation of findings, each 
study went through a process of quality assessment. A checklist was drawn up using the 
guidelines laid out in the HuGE Review Handbook, a document developed to assist the 
integration of evidence from human genomic epidemiological studies (Little & Higgins 
2006). In each study we assessed selection bias, bias or error in outcome ascertainment, 
information bias (analytical validity of genotyping and, in studies of gene- environment 
interaction, the validity of exposure assessment) and confounding.  
 
Searching the databases resulted in 543 hits.  Duplicates were removed and abstracts and 
titles were reviewed with reference to the inclusion criteria.  Overall, 506 papers were 
rejected for one or more of the following reasons: they were duplicates; they did not use 
human participants, they focused on hereditary of genetic markers and the mental health of 
the infant at some stage in his/her life rather than the mother’s mental health; they did not 
investigate genetic or epigenetic markers; or they did not investigate the mother’s postnatal 
mental health. The results can be viewed in Table 1.   
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Study 
Objectives 
and 
Hypothesis 
clearly 
stated 
Clear 
eligibility 
criteria for 
participants 
Informatio
n Bias -
Genotyping 
Selection Bias 
Information 
Bias - 
Assessment of 
environmental 
factors 
Information 
Bias - 
Assessment of 
Depression 
Ethnicity for 
participation 
restricted 
Statistical. 
methods 
replicable 
HWE 
Assessed 
Sufficient 
descriptive 
data 
Genotype 
frequencies 
stated 
Bell et al. 
2015 
Yes Yes QC 
Sample over weighted for teenage and 
depressed mothers 
n/a No No Yes Yes Yes Yes 
Osborne et 
al. 2015 
Yes Yes n/a 4 cohorts n/a 4 cohorts n/a Yes n/a Yes n/a 
Tan et al. 
2015 
Yes Yes QC 
Matched cases from obstetric and 
psychiatric clinic 
n/a No 
Chinese 
ancestry 
Yes Yes Yes Yes 
Alvim-
Soares et al. 
2014 
Yes No QC No n/a 
30.9% 
depressed 
Brazilian 
women of 
ED 
Yes Yes Yes Yes 
Frank et al. 
2014* 
Yes Yes NDG No n/a E2PN NDG Yes unknown available No 
Guintivano 
et al. 2014 
Yes Yes n/a Women with psychopathology n/a No n/a Yes n/a Yes n/a 
Mehta et al. 
2014 
Yes Yes n/a Women with psychopathology n/a No No Yes n/a Yes n/a 
Schneider et 
al. 2014 
Yes No QC 
No (excluded women with psychiatric 
illness history 
n/a E2-3 dpn No Yes Yes Yes Yes 
Stergiakoue 
et al. 2014 
Yes Yes QC No n/a No No Yes Yes available Yes 
Zhang et al. 
2014 
Yes Yes QC Depressed postnatal. Women No No 
Chinese 
population 
Yes unknown Yes Yes 
Alvim-
Soares et al. 
2013 
Yes No NDG No n/a No 
Brazilian 
women of 
CD 
Yes Yes Yes Yes 
El-Ibiary et 
al. 2013 
Yes Yes QC No No No No Yes unknown Yes Yes 
Engineer et 
al. 2013 
Yes Yes QC No n/a E2PN Caucasian Yes Yes No Yes 
Jonas et al. 
2013 
Yes No NDG No No No No Yes Yes Yes Yes 
Khabour et 
al. 2013 
Yes Yes QC No n/a No No Yes Yes Yes Yes 
Mileva-Seitz 
et al. 2013 
Yes Yes NDG No No No Caucasian Yes Yes Yes Yes 
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Pinsonneal.t 
et al. 2013 
Yes Yes QC 
Women recruited with mood/anxiety/stress 
disorders 
n/a No No Yes Yes Yes Yes 
Tavares 
Pinheiro 
2013 
Yes Yes NDG No No No No Yes Yes Yes Yes 
Fasching et 
al. 2012 
Yes Yes QC 
No (excluded women with psychiatric 
illness history 
n/a E2-3dpn No Yes Yes Yes Yes 
Gelabert et 
al. 2012 
Yes Yes NDG Psychiatric Caucasian postnatal. women No No Caucasian Yes Yes Yes Yes 
Lewis et al. 
2012 
Yes Yes NDG 
Sample over weighted for teenage and 
depressed mothers 
No No Caucasian Yes No Yes Yes 
Mehta et al. 
2012 
Yes Yes NDG 
mean maternal. age older than original. 
Sample 
No No 
German 
Women 
Yes Yes Yes Yes 
Comasco et 
al. 2011 
Yes Yes QC 
Case control, PND over represented in 
comparison to population 
NDRV No No details Yes Yes Yes Yes 
Comasco et 
al. 2011 
Yes Yes QC 
Case control, PND over represented in 
comparison to population 
NDRV No No details Yes Yes Yes Yes 
Binder et al. 
2010 
Yes Yes QC No n/a No No Yes Yes Yes Yes 
Costas 2010 Yes Yes QC No n/a No No Yes Yes Yes Yes 
El-Ibiary et 
al. 2010* 
Yes No NDG No No No No Yes unknown Yes Yes 
Figueira et 
al. 2010 
Yes Yes NDG No No No No Yes Yes Yes Yes 
Mitchell et 
al. 2010 
Yes Yes NDG 
Sample over weighted towards unwed 
mothers 75% 
No CIDI-SF No Yes unknown Yes Yes 
Doornbos et 
al. 2009 
Yes Yes NDG 
No (women with diabetes and vegan diet 
excluded) 
n/a No Caucasian Yes Yes Yes Yes 
Lin et al. 
2009 
Yes Yes NDG No n/a No No Yes Yes Yes Yes 
Mahon et al. 
2009 
Yes Yes QC 
Women with postnatal bipolar or PND 
symptoms 
n/a No No Yes Yes Yes n/a 
Xie L & 
Innis 2009 
Yes Yes QC No n/a No No Yes Yes Yes Yes 
Sanjuan et 
al. 2008 
Yes Yes NDG No n/a No No Yes Yes Yes Yes 
Josefsson et 
al. 2004 
Yes Yes NDG Depressed women n/a No Caucasian Yes n/a Yes Yes 
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QC - details given of quality control procedures; NDG - details given of quality control procedures E2PN - EPDS 2-8 week postnatal.ly; E2/3dpn - EPDS 2-3 days postnatal. measures end of 
pregnancy; 30.9% depressed - EPDS>=13 & Assessed byes psychiatrist at 8 weeks postpartum (30.9% depressed); Available – reported elsewhere; NDRV -No details given re reliability or 
validity of measures; Brazilian women of ED -Brazilian women of European descent; Brazilian women of CD -Brazilian women of Caucasian descent; 4 cohorts -4 cohorts some psychiatric 
interview while others had a range of self-report measures *Conference abstrac 
 
Sun et al. 
2004 
Yes Yes QC No inclusion/exclusion criteria n/a No No Yes Yes Yes Yes 
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References 
retrieved 
from 
Medline 
N=151 
References 
retrieved 
from 
PILOTS 
N=10 
 
References 
retrieved 
from 
EMBASE 
N=105 
 
References 
retrieved 
from 
PsychInfo 
N=64 
 
References 
retrieved 
from 
Scopus 
N=213 
 
Total references retrieved (including duplicates) 
N=543 
Total full papers 
screened 
N=42 
Duplicates removed 
and articles rejected at 
title/abstract  
N=501 
Rejected full papers 
as they did not meet 
the inclusion criteria 
or quality appraisal 
N=5 
Papers included from references 
when full papers were screened, 
references checked and sourced 
N=0 
Total papers included in literature review 
N=37 
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2. Results 
37 studies were identified that reported on associations between PND and single nucleotide 
polymorphisms (SNPs), deletion/insertion polymorphisms or epigenetic modifications.  As not 
all studies used a clinical diagnosis of depression (21 studies measured elevated symptoms of 
depression), the term postnatal depression (PND) has been used throughout to refer to both a 
formal diagnosis of depression or elevated symptoms of depression.  Two studies assessed 
levels of anxiety in addition to PND (Lin et al, 2009; Sun et al, 2004.)  The majority of the 
studies were carried out with European, Caucasian women.    
 
The literature search identified three genome-wide studies (GWAS) (Byrne et al, 2014; Mahon 
et al, 2009; Mehta et al, 2014) and two studies that investigated multiple polymorphisms in a 
large number of genes (Coastas et al, 2010; El-Ibiary et al, 2013).  The majority of studies focus 
on polymorphisms within one or two candidate genes, chosen because they are linked to the 
aetiology of other mental illnesses such as depression and anxiety, or to biological changes 
brought about by pregnancy or childbirth. These polymorphisms impact the function of 
monoamines  (Alvim-Soares et al, 2013; Binder et al, 2010; Comasco et al, 2011; Doornbos et 
al, 2009; Fasching et al, 2012; Gelabert et al, 2012; Khabour et al, 2013; Lin  et al, 2009; Mehta 
et al, 2012; Mitchell et al, 2011; Pinheiro et al, 2013; Pinsonneault et al, 2013; Sanjuan et al, 
2008; Sun et al, 2004),  Brain Derived Neurotrophic Factor (BDNF) (Comasco et al, 2011; 
Figueira et al, 2010), the Hypothalamic-Pituitary-Adrenal (HPA) Axis (Engineer et al, 2014; 
Frank et al, 2014; Schneider et al, 2014; Stergiakoule et al, 2014) or reproductive hormones 
(Alvim-Soares et al, 2014; Jonas et al, 2013;  Mileva-Seitz et al, 2013.) The FADS1/FADS2 
gene cluster (Xie & Innis 2009), the MTHFR gene (Lewis et al, 2012) and the cytochrome 
P450 2D6 genotype (Josefsson et al, 2004) have also been investigated in association with 
PND.  
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Polymorphism 
or Epigenetic 
Modification 
Study Sample 
Environmental 
Stressor 
Assessment 
of 
Depression 
Main Association reported between variant 
and PND 
 
 
Genome wide Bryne et 
al, 2014 
(N=10893) n/a SCI No associations reported 
16,916 SNPs in 
the regions of 
the best linkage 
peaks 
Mahon et 
al, 2009 
 
(N=1210,759)  
n/a SCI Genetic variations on chromosomes 1q21.3-
q32.1 and 9p24.3 may increase susceptibility 
to PND. Strongest implicated gene was 
HMCN1. 
5-HTTLPR Zhang et 
al, 2014 
Hans Chinese 
women with a 
history of 
PND (N=220) 
and healthy 
controls 
(N=193) 
Socio-
demographics 
Alcohol 
consumption, 
Smoking, CA&P  
SLEDP 
SCI within 
12 months 
PN 
 LL carrier status in the presence of maternal 
pregnancy complications, prenatal maternal 
infection, prenatal maternal folate deficiency, 
SLEDP or age over 32.8 years is associated 
with higher prevalence rates for PND.  
5-HTTLPR Pinheiro 
et al, 2013 
Postpartum 
women 
(N=276) 
socio-
demographic 
variables, 
alcohol 
consumption, 
tobacco smoking 
and SLEDP 
EPDS &SCI 
45-90 days 
PN 
L carrier status in the presence of stressful life 
events (SLEs) is associated with PND. 
5-HTTLPR 
polymorphism 
Pinsonnea
ult et al, 
2013 
Brazilian 
women 
(N=276) 
SLE EPDS & SCI 
PN 
L allele carrier status in presence of SLE is 
association with PND. 
5-HTTLPR 
polymorphism 
Mehta et 
al, 2012 
Caucasian 
German 
women 
(N=419) 
satisfaction with 
partner and 
negative life 
events 
EPDS during 
3rd 
trimester, 2-
3 days and 
6-8 months 
PN 
S allele carrier status predicted PND in 
presence of SLEs. 
5-HTTLPR 
polymorphism 
Binder et 
al, 2010 
 (N=274) n/a Baseline – 
SCI <=8 
weeks and 9-
24 weeks PN 
Hamilton 
Rating scale 
for 
Depression 
and SCID 
Mood 
Module 
S carrier status in the presence of a maternal 
history of depression was associated with 
PND in early postpartum period. 
5-HTTLPR and 
STin2 
Gelabert 
et al, 2012 
Spanish 
(N=237) 
n/a EPDS 1 and 
24 weeks PN 
5-HTT low-expressing genotypes at one loci 
was associated with PND. 
5-HTTLPR and 
STin2 VNTR 
Mitchell 
et al, 2011 
(N=1206) socioeconomic 
status measured 
by education  
SCI S and 12 carrier status associated with a bi-
directional outcome making women more 
sensitive to their environment. 
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5-HTTLPR and 
STin2 VNTR 
polymorphisms 
Sanjuan et 
al, 2008 
Spanish 
women 
(N=1804) 
n/a EPDS & SCI 
at 2-3 days, 
8 and 32 
weeks PN 
High expression genotype associated with 
PND. 
81 SNPs in 12 
genes 
El-Ibiary 
et al, 2010 
& 2013 
Postnatal 
women 
(N=48) 
Dyadic 
Adjustment 
Scale, MOS 
Social Support 
Survey, Life 
Threatening 
Events Survey, 
and QIDS-SR16 
scale 
SCI PN  3 SNPs in HTR2A associated with PND. 
SNPs in TPH2 
and SNPs that 
are known to be 
of functional 
relevance were 
genotyped 
Fasching 
et al, 2012 
Caucasian 
women 
(N=361) 
n/a EPDS 3rd 
Trimester, 2-
3 days & 6 
months PN 
A haplotype block in promoter region of 
TPH2 was associated with depression 
pregnancy and postnatally. 
TPH2 gene 
2755C>A 
Lin et al, 
2009 
Chinese 
women 
(N=200) 
n/a 36 weeks 
AN & 8 and 
18weeks PN 
- SCI 
TPH2 275A allele was reported only in 
women with co morbid PND and anxiety - 
estimated disease risk was 1.73  
5 SNPs from 
TPH1  
Sun et al, 
2004 
Pregnant 
Taiwanese 
women 
(N=206) 
n/a SCI  T27224C was associated with co morbid PND 
and anxiety 
TPH1 (218A>C) 
TPH2 
(1463G>A) and 
SLC6A4 (L/S) 
Khabour 
et al, 2013 
  (N=370) marital status, 
depression 
history, living 
status (with 
immediate or 
extended family) 
EPDS PN No association  
Val158Met 
COMT 
Alvim-
Soares et 
al, 2013 
Brazilian/Cau
casian women 
(N=116) 
n/a EPDS>= 13 
at 8 weeks 
PN 
Association reported between Met carrier 
status and PND 
5HTT (l/S) 
COMT, MAOA 
Comasco 
et al, 2011 
Swedish 
women(N=27
5) 
SLE, History of 
depression, 
maternity 
stressors 
EPDS at 6 
weeks and 6 
months PN 
Association between COMT at 6 weeks but 
not 6 months 
 
MAOA, 5-HTT 
and COMT 
Doornbos 
et al, 2009 
Dutch women 
(N=89) 
n/a EPDS at 16 
and 36 
weeks AN, 6 
& 12 weeks 
PN  
 
Associations reported during late pregnancy 
and early postnatal period 
BNDF 
Val66Met, 
5HTT (L/S), 
PER2 
Comasco 
et al, 2011 
Swedish 
(N=275) 
Season of 
delivery, SLEs, 
maternity 
stressors 
EPDS at 6 
weeks and 6 
months PN 
MET carrier status associated with PND only 
when mothers delivered in winter or autumnal 
months.  
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BNDF 
Val66Met 
Figueira 
et al, 2010 
 (n=227) n/a EPDS and 
SCI 
No association 
SNPs from 
CRHR1 and GR 
Tan et al, 
2015 
Women of 
Chinese 
descent 
(N=725) 
n/a SCI PN No association 
FKBP5, NR3C1 
and CRHR1 - 9 
SNPs from these 
genes were 
grouped into 
haplotypes 
Schneider 
et al, 2014 
German 
(N=431) 
n/a EPDS 3rd 
Trimester, 
shortly after 
birth and 6-8 
months PN 
No association 
Bcll (GR) 
(rs853180) and 
ER22/23EK 
(rs10482704) 
and CRHR1 
(rs1876828, 
rs242939 and 
rs242941) 
Stergiako
ule et al, 
2014 
Pregnant 
women from 
the UK 
(N=8340) 
n/a EPDS 18 
weeks AN 
and 8 week 
PN 
Weak associations reported between SNPs of 
CRHR1 and prenatal depression and PND.   
Bcll (GR) 
(rs41423247) 
and ER22/23EK 
(rs6190) and 
haplotype of the 
CRHR1  
Engineer 
et al, 2013 
English 
Caucasian 
pregnant 
women 
(N=200) 
n/a EPDS during 
pregnancy 
and 2-8 
weeks PN 
rs242939 was associated with PND. 
rs242939 is associated with depression only 
during pregnancy. 
CRHR1 gene 
(rs7209436/rs24
2924/rs242940/r
s173365/rs11040
2) and CRHR2 
(rs3779250)  
Frank et 
al, 2014 
Pregnant 
women from 
the UK 
(N=250) 
n/a EPDS 24-26 
weeks AN 
and PN 
2 SNPs individually (rs242924, rs173365) 
showed a sig protective effect (OR 0.41(0.19-
0.90) p=0.024 and OR 0.37 (0.16-0.87) 
p=0.024 respectively.) The TATGG haplotype 
was also protective. 
508 SNPs in 44 
genes 
Costas et 
al, 2010 
Spanish 
postnatal 
women 
(N=1804) 
n/a EPDSand 
STAI 2-3 
days, 8and 
32 weeks 
PN. If 
EPDS>=9 
SCI 
3 SNPs at protein kinease C beta (PRKCB) 
significantly associated with PND. 
HMNC1 
rs2891230 
Alvim-
Soares et 
al, 2014 
Brazilian/Eur
opean 
(N=110) 
n/a EPDS>= 13 
at 8 weeks 
postnatal 
Heterozygosity associated with PND. 
OXT peptide 
rs2740210 
rs4813627 and 
OXT receptor 
rs237885 
Jonas et 
al, 2013 
 MAVAN* 
(N= 431) 
early life 
adversity 
CES-D 6 
months PN 
rs2740210 interacted with early life adversity 
to predict PND 
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OXT peptide 
rs2740210 
rs4813627  
Mileva-
Seitz et al, 
2013 
Caucasian 
mothers from 
MAVAN* 
(N=187)  
quality of care 
mothers 
experienced in 
early life 
CES-D 12-
24 weeks 
AN & 6 
months PN 
Both SNPs interacted with environmental 
factor to predict PND 
FADS1/FADS2 Xie L & 
Innis SM 
2009  
Canadian 
Caucasian 
(N=69) 
n/a EPDS 
36weeks AN 
and 8 & 24 
weeks PN 
Associations reported in both antenatal and 
postnatal period 
CYP2D6 
genotypes 
Josefsson 
et al, 2004 
Caucasian 
(N=145) 
n/a EPDS 35-36 
weeks AN, 
6-8 weeks 
and 6 
months PN 
No association 
Methylenetetrah
ydrofolate 
reductase 
(MTHFR) 
C677T  
Lewis et 
al, 2012 
Pregnant 
women 
(N=6809) 
Folic acid 
supplementation 
EPDS 18 & 
32 weeks 
AN and 8 
and 2 & 8 
months PN 
No association 
Serum hormone 
and PPD specific 
DNA 
methylation in 
the OXTR  
Kimmel et 
al, 2016 
Subjects 
derived from 
the JHPC & 
data collected 
by Mehta et al 
(2014) & 
FRAMES 
(N=240) 
n/a Various 
approaches 
including 
SCI, EPDS, 
BDI & 
HDRS, AN 
and PN 
 
Moderate evidence for an interaction of CpGs 
in the OXTR with childhood abuse status to 
mediate PND 
Replication 
study testing 
model 
formulated by 
Guintivano et al 
2014 
Osborne 
et al, 2015 
Women 
without a 
history of 
psychiatric 
illness  
(N=240) 
n/a Various 
approaches 
including 
SCI, EPDS, 
BDI & 
HDRS, AN 
and PN, self 
report. 
 
Good accuracy of predictive model reported 
(AUC of 0.81(95% CI: 0.68-0.93, p=0.01) 
DNA 
methylation of 
HP1BP3 AND 
TTC9B genes 
after 
administration of 
E2 
Guintivan
o et al, 
2014 
Women with 
a history of 
major 
depression or 
bipolar 
disorder 
(JHPC) 
(N=93) 
n/a SCI Two biomarkers loci at HP1BP3 and TTC9B 
found to be predictive of PND when combined 
with blood count data  
OXTR DNA 
methylation 
levels OXTR 
rs53576 and 
rs2254298 
Bell et al, 
2015 
Pregnant 
women 
(N=500) 
psychosocial 
factors 
EPDS AN & 
PN 
Interaction between increased methylation and 
rs53576 GG carrier status associated with 
PND 
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Environmental factors were measured in combination with genetic polymorphisms in 11 of the 
studies and included stressful/negative life events, satisfaction with partner, season of delivery, 
maternity stressors, history of depression or other psychiatric illness, social support, folic acid 
supplementation, socioeconomic group and early life adversity.    
 
In this review, studies have been classified as genome-wide association studies, targeted SNP 
genetic studies or epigenetic studies.   
 
Table 2 Summary of the included studies detailing the author, sample, genetic/epigenetic markers, environmental factors 
and main findings of the studies. 
MANVA - Maternal adversity, Vulnerability and Neurodevelopment study over 75% Caucasian primary sample n=201 (Hamilton, 
replication sample Montreal n=151) FRAMES – Franconian Maternal Health Evaluation studies; JHPC – John Hopkins Prospective PPD 
sample SLE –stressful life events SLEDP – stressful life events that occur during pregnancy CA&P Prenatal exposure to chemical agents 
or pollutants EPDS- Edinburgh Postnatal Depression Scale SCI – Structured clinical interview/clinical diagnosis STAI - Spielberger State-
Trait Anxiety Inventory HDRS - Hamilton Depression Rating Scale BDI - Beck Depression Inventory  
 
2.1 Genome-wide association studies  
Byrne et al (2014) (N=10 893) did not detect any genome wide associations specifically for 
PND. However, a larger genome wide association alongside linkage studies conducted by 
Mahon et al (2009) (N=1210759) identified genetic variability on chromosomes 1q21.3-q32.1 
and 9p24.3, that may increase susceptibility to PND. The hemicentin-1 gene was the most 
strongly implicated gene when fine mapping was carried out (nominal p=0.00017). This gene 
encodes an extracellular protein that contains four estrogen receptor-binding sites.  
 
2.2 Targeted Genetic Studies  
Monoamines 
Genome wide. 
Gene expression 
and hormones 
levels 
Mehta et 
al, 2014 
Women with 
psychopatholo
gy (N=62) 
replication 
cohort (n=24) 
n/a EPDS, 
HDRS & 
BDI - 1st 
trimester, 3rd 
Trimester 
and 3 
months PN  
116 transcripts were identified that allowed 
prediction of PND status with 88% accuracy 
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Polymorphisms that affect monoamine signaling have been a natural focus for genetic studies 
of PND because of the well-characterized involvement of monoamines, particularly serotonin, 
in depression at other life stages. The most frequently studied polymorphism within the 
serotonin system is a 44-base insertion/deletion in the the serotonin transporter (5HTT) gene 
that encodes the serotonin transporter (5-HTTLPR). Both the S allele and the L allele have 
been linked to PND (Gelabert et al 2012; Pinheiro et al 2013; Zhang et al 2014; Mehta et al 
2012: Gelabert 2012; Binder 2010; Zhang 2014; Sanjuan et al 2008.)  Inconsistencies in 
determining the risk allele are likely due some studies examining environmental factors 
alongside genotype and others examining the two in isolation.  
 
Polymorphisms in the tryptophan hydroxylase-2 (TPH2) gene, three SNPS in the serotonin 
receptor 5-HTR2A gene (rs6311, rs2070040, and rs6314), a polymorphism in the mono-amine-
oxidase type A gene (MAOA-uVNTR) and a functional SNP at position 158 the catechol-O-
methyl transferase (COMT) gene are all linked to increased risk for PND (Fasching 2012; El-
Ibiary et al. 2013 Doornbos et al 2009; Comasco et al 2011; Alvim-Soares 2013), However,  
no associations are found between the TPH1 gene and PND (Sun 2004; Khabour et al 2013).  
 
 
 
Brain Derived Neurotrophic Factor 
Alterations in expression levels of brain derived neurotrophic factor (BDNF), a growth factor 
with important functions in neuronal development and neuroplasticity, have been associated 
with variety of psychiatric disorders (Martinowich and Lu 2008).  Studies suggest that the 
BDNF Val66Met polymorphism alters both the rate of protein secretion with the methionine 
(Met) variant causing insufficient secretion in comparison to the Valine (Val) variant (Groves 
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2007) and Met carrier status is associated with reduced hippocampal volume (Frodl et al, 
2007). Carrier status was not in itself found to be associated with PND by either a case-
control study (N= 275) from a population-based Swedish cohort (Comasco et al., 2011) or in 
a random sample (N=227) of women (Figueira et al 2010).  However, a significant 
association between BDNF Met66 carrier status and PND symptoms was detected at six 
weeks postpartum in mothers who delivered during autumn and winter months, even when 
controlling for pre-partum and postpartum environmental risk factors in the case control 
study (Comasco et al., 2011).   
 
Hypothalamic-Pituitary-Adrenal (HPA) Axis 
Six studies examined the genetic variability in genes linked to stress reactivity (Engineer et al 
2013; Stergiakouli 2014; Frank et al 2014; Schneider et al 2014; Tan et al 2015; Costas et al 
2010). Genetic variability in the corticotrophin releasing hormone receptor 1 gene (CRHR1) 
which binds corticotrophin releasing hormone, a potent mediator of physiological responses to 
stress, FK506 binding protein 5 gene (FKBP5), a member of the immunophilin family which 
plays an important role in glucocorticoid receptor signaling and the glucocorticoid receptor 
gene itself (GR and NR3C1) were investigated in association with PND.   Initially, SNPs in the 
CRHR1 and the GR appeared to be candidate predictive biomarkers for PND (Frank et al 2014; 
Engineer et al 2013).  However, a fully powered replication study (N=8340) did not confirm 
these findings (Stergiakouli 2014) and reported only a weak association, between the SNPs in 
the CRHR1 gene and both antenatal depression and PND.  Further to this, no associations with 
PND were reported by either Schneider et al (2014) or Tan et al (2015) between haplotypes or 
SNPs occurring in the FKBP5, NR3C1 and CRHR1 genes.  Both of these case-control studies 
had good sample sizes (N=431 and N=725 respectively). This suggests that the associations 
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between CRHR1 gene polymorphisms and PND are not strong enough to act as predictive 
markers at a population level.    
 
Costas et al (2010) carried out a large multi-centre cohort study (N=1804) of Spanish women 
which included 508 SNPs in 44 genes and reported a potential role for a haplotype (GG-TT-
CC at three individual SNPs rs2051684, rs381901 and rs198183) in the protein kinase C beta 
gene (PRKCB) in conferring risk of PND.  PRKCB is involved in the signal transduction 
pathways that regulate the HPA axis (Shelton 2007.) No other studies have  investigated this 
haplotype in association with PND to date and further study in other sample populations are 
required to determine its utility as a predictive marker. 
 
 Hormones of the Reproductive System 
Estrogen has long been thought to play a role in the aetiology of PND and associations between 
genetic polymorphisms that affect estrogenic function and PND have been reported (Mahon et 
al 2009; Alvim-Soares et al 2014). Following the earlier reported genome wide linkage study 
by Mahon et al (2009), a smaller targeted study by Alvim-Soares et al (2014) also reported an 
association between SNPs in the hemicentin-1 gene and PND. Specifically, they identified the 
GA genotype of an intronic SNP rs2891230 within the gene as being associated with PND (chi-
square = 15.64; p<0.01; df=2). A polymorphism in the estrogen receptor gene, ESR1 (the 
upstream TA microsatellite repeat), has also been associated with PND (Pinsonneault et al 
2013); the long allele of this polymorphism associated with increased EPDS scores.  A potential 
interaction between the serotonin transporter (S allele of the 5HTTLPR) and ESR1 (L allele) 
was detected. Although Costas et al (2010) included genes involved in the regulation of sex 
hormones in their study of 44 candidate genes and PND, they reported no associations. 
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However, neither the rs2891230 nor the rs2077647 SNPs were included in their analysis and 
the positive associations reported indicate these SNPs merit further detailed investigation.  
 
SNPs related to oxytocin function have also been investigated. Oxytocin (OXT) is a nine-
amino acid peptide which functions both as a hormone during labour and lactation, and as a 
neurotransmitter that is released when a mother interacts with her infant (Magon & Kalra 
2011).  The role that oxytocin has in mediating social behaviours are central to forming 
healthy relationships and has led to a growing interest in the contribution oxytocin may have 
in the pathophysiology of neuropsychiatric disorders such as depression (Cochrane et al 
2013).  Oxytocin is associated with decreased cortisol levels and lower anxiety in stressful 
social situations and reduced amygdala activity in threatening situations (Olff et al, 2013).  
Jonas et al (2013) and Mileva-Seitz et al (2013) reported associations between SNPs of the 
oxytocin gene (rs2740210, rs4813627) and PND when the mother had experienced negative 
childhood experiences, such as early childhood adversity or a lack of quality of care from her 
own mother. Childhood trauma scores were moderated by OXT rs2740210 genotype; women 
who had the CC genotype experienced higher level of depression than women with at least 
one A allele (Jonas et al 2013). Mileva-Seitz et al (2013) concurred that early life experiences 
had a stronger moderating effect for this genotype (CC) and also for the GG genotype in the 
rs4813627 SNP.  While SNP rs237885, which occurs in the oxytocin receptor gene, was 
associated with antenatal depression scores it was not associated with PND scores (Mileva-
Seitz et al 2013).  When considering the strength of the evidence from these two studies it 
should be noted that both of these studies drew their sample from the same source – the 
Maternal Adversity, Vulnerability and Neurodevelopment Study so they are not independent 
cohorts, and replication of these findings in additional populations would add strength to their 
use as markers of PND. 
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Additional genetic markers 
Quantitative trait analysis showed that genetic variability in the FADS1/FADS2 gene cluster 
that contributes to variability in blood lipid fatty acids is associated with perinatal depression; 
rs174575 carrier status was associated with increased risk of depressive symptoms at both 36 
weeks gestation and at six months postpartum (Xie & Innis 2009), suggesting that this may be 
a useful marker of depression but it is not specific to postnatal onset. The haplotype GTCT in 
rs174553, rs99780, rs174575, rs174583 respectively was also associated with PND risk at 36 
weeks gestation (p=0.028).  Additionally, studies have examined the interaction between 
MTHFR C677T genotype and folic acid supplementation during pregnancy (Lewis et al 2012) 
and the cytochrome P450 2D6 (CYP2D6) genotype (Josefsson et al 2004) and risk of PND but 
no associations were identified.  
 
2.3 Epigenetic Studies  
DNA methylation is the most extensively studied epigenetic mechanism to date and involves 
the addition of a methyl group to the 5’ carbon of a cytosine molecule (Moore 2013). The 
presence of this methyl group physically blocks transcription factors from binding to DNA, 
and in general methylation of the promoter region of a gene decreases expression.  
Methylation levels can be impacted by genetic differences and can be altered as a a result of 
environment exposures.  Changes in DNA methylation can be heritable and have been shown 
to contribute to the psychopathology of mental health disorders (Bale et al. 2010).  Four 
studies that investigated DNA methylation in association with PND were identified, all of 
which reported positive associations.  
Oxytocin is a key regulator of stress and anxiety and interacts with psychosocial risk factors 
and gonadal hormones (Olff et al, 2013). Genetic and epigenetic variability in the oxytocin 
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receptor (OXTR) gene are linked to PND. Bell et al. (2015) identified an interaction between 
rs53576 and methylation in the OXTR gene amongst women who did not have depression 
prenatally but developed PND. Women with the GG genotype showed 2.63 greater odds of 
PND for every 10% increase in methylation level, whereas methylation was unrelated to PND 
amongst “A” carriers. However, no association was found for women who had symptoms of 
antenatal depression, suggesting that this interaction may be specific for postnatal onset. 
Guintivano et al. (2014), identified estrogen-induced changes in DNA methylation in two 
genes, HP1BP3 and TTC9B, that were common to both mouse hippocampus samples 
following long-term treatment with estradiol, and in blood samples from pregnant women 
with pre-existing mood disorders. DNA methylation status, and corresponding gene 
expression levels of HP1BP3 and TTC9B were highly predictive of PND with an area under 
the receiver operator characteristic curve (AUC) of 0.96 in women with antenatal depression 
and euthymic women. Further evidence supporting the use of DNA methylation levels in 
HP1BP3 and TTC9B as predicative biomarker loci for PND was demonstrated in a follow up 
study by Osborne at al. in 2015. Employing a statistical model including the methylation 
status of HP1BP3 and TTC9B, PND status was correctly predicted in a cohort of high-risk 
women, as well as in an independent cohort of women without a previous diagnosis of a 
psychiatric disorder with an AUC of 0.81.  
OXTR expression is influenced by exposure to gonadal hormones including estrogens. DNA 
methylation levels in an intronic region of the OXTR gene proximal to an estrogen binding 
site were found to be predictive of PND in both a cohort of women drawn from the general 
population and a cohort of women with a history of psychiatric illness (Kimmel et al 2016). 
The investigators also reported a significant interaction between methylation at two OXTR 
CpG sites (chr3, positions 8810078 and 8810069) and childhood abuse in determining risk 
23 
 
for PND.  Additionally, they reported that DNA methylation status negatively correlated to 
serum estradiol levels, suggesting that the patterns indicative of PND are mediated by 
hormone exposure. 
 2.4 Gene Expression Studies 
Only one study to date has examined the utility of gene expression patterns as predictors of 
PND. Using a genome wide approach Mehta et al. (2014) identified a group of 116 
transcripts that predicted PND in a high-risk cohort who were euthymic in the third trimester 
of pregnancy with 88% accuracy. Network analysis of the candidate transcripts indicate that 
39 of the 116 genes identified are involved in estrogen signaling. These results suggest that 
PND risk can be predicted prenatally in those who are already experiencing mood problems; 
however, this approach has not yet been tested for women who have no symptoms prenatally.  
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Gene Polymorphis
m / 
modification 
Suggested Mechanism Results Papers 
5-HTT 5-HTTLPR 5-HTTLPR status interacts with 
environmental factors to increase 
risk of PND 
‘S’ allele status in the presence of 
SLEs or a history of depression is 
associated with PND  
‘L’ allele status in the presence of 
SLEs is associated with PND 
Binder 2010; Mehta et 
al 2012; Gelabert et al 
2012; Pinheiro et al 
2013; Zhang et al 
2014 
5-HTT 5-HTTLPR 
        & 
STin2 VNTR 
 
Genotype makes women more 
reactive to the environment.  
 
Tryptophan depletion during the 
third trimester of pregnancy and 
the early postnatal period makes 
women with high expressing 
genotypes vulnerable to PND at 
these times.   
‘S’ allele combined with 10’ 
allele carrier status is protective in 
a positive environment and 
confers risk in a negative 
environment 
 
Genotype LL of 5-HTTPLR and 
STin2.12 was associated with 
depressive symptoms in a dose-
response fashion at 8 weeks 
postpartum but not at 32 weeks. 
Mitchell et al 2011 
 
 
Sanjuan et al 2008 
TPH1  
TPH2 
 
TPH1 
T27224C 
TPH1 A218C 
THP2 
C2755A 
TPH1 & TPH2 code for two 
isoforms of Tryptophan 
hydroxylases (TPH), the rate 
limiting enzymes in serotonin 
synthesis and are thought to play 
a critical role in regulating 
serotonin metabolism. Under 
hormonal influence 
polymorphisms in TPH1 & TPH2 
will affect enzyme activity, 
impacting rates of serotonin 
metabolism. 
TPH1 27224C and TPH2 2755A 
alleles were associated with co-
morbid perinatal major depression 
and anxiety disorder.  (TPH1 
27224C conferred a strong 
protective effect (odds ratio=0.27; 
95% confidence interval = 0.11-
0.7) while TPH2 2755A allele 
was found only in women with 
(p=0.043) and exhibited a 
dominant gene action (p=0.038) 
with an estimated disease risk of 
1.73.) 
TPH2 haplotypes were associated 
with depression both during 
pregnancy and postpartum. 
No association was found 
between TPH1 A218C and PND 
at 4-6pn 
Sun et al 2004 
Lin et al 2009 
 
 
 
 
Fasching et al 2012 
Khabour et al 2013 
COMT COMTVal15
8Met 
The polymorphism affects 
enzyme functionality in a 
trimodal fashion: high function 
for the Val/Val genotype; 
intermediate function for the 
Val/Met genotype and low 
activity for the Met/Met 
genotype.  Difference in enzymic 
activity due to genotype in 
COMTVal158Met affect 
monoamine function. 
AA genotype (Met/Met) was 
associated with PND (p=0.01) 
After 1,000 permutation test, the 
adjusted p value remained sig 
(p=0.05)  
 
Alvim-Soares et al 
2013 
 
 
 
 
MAOA 
and 
COMT 
COMTVal15
8Met and 
MAOA 
VNTR 
The gene coding for MAOA 
codes for an enzyme involved in 
the degradation of serotonin, 
dopamine and noradrenalin. The 
VNTR polymorphism occurring 
in the promoter region consisting 
of a 30bp repeated sequence.  The 
3aR and 4R are transcribed 10 
times more efficiently compared 
to other variants i.e. 2R, 3R and 
5R.  The combination of low 
variants in COMT and MAOA is 
also found to be associated with 
altered stress response.  Women 
with this genotype may be more 
sensitive to the increasing stress 
and/or decreasing  synthesis of 
Women carrying low activity 
variants of MAOA and COMT 
showed increased scores at 36 
weeks of pregnancy and 6 weeks 
postpartum but not during early 
pregnancy or 12 weeks 
postpartum.  
 
Doornbos et al 2009 
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serotonin that occur as pregnancy 
progresses.  
BDNF  Val66Met Met allele is associated with 
impaired intracellular trafficking 
and secretion as well as altered 
human hippocampal function and 
smaller grey matter volumes in 
several brain regions.   
No association between 
Val66Met carrier status and PND 
was reported. 
A sig. association between Met66 
Carrier status and development of 
PND symptoms at 6 weeks 
postpartum was evident in mother 
delivering during autumn/winter.  
Figueira et al 2010 
Comasco et al 2011 
 
BDNF 
and 5-
HTTLPR 
 Polymorphisms in BDNF have 
been associated with 5-HHT 
availability with Val allele 
carriers having higher levels of 
availability in several regions of 
the brain. 
Moreover, serotonin transporter 
binding levels in the brain have 
been shown to increase during 
autumn and winter and as brain 
tryptophan levels decrease during 
the perinatal period BDNF 
Val66Met genotype could interact 
with season of delivery to 
influence serotonin availability 
and in turn the risk of depression. 
No gene-gene interaction was 
found. A cumulative effect was 
detected with carriers of a greater 
number of 5-HTTLPR S and 
BDNFVal66Met Met alleles 
reporting higher EPDS scores if 
delivering during autumn/winter 
Comasco et al 
PRKCB haplotype of 
rs2051684, 
rs381901 and 
rs198183 
PRKCB is involved in the signal 
transduction pathways that 
regulate the HPA axis (Shelton 
2007.)   
 
Genotype G/G-T/T-C/C at SNPs 
rs2051684, rs381901 and 
rs198183  
Costas et al 2010 
HMCN1 rs2891230 This gene encodes an 
extracellular protein that contains 
four estrogen receptor-binding 
sites.   
Genome-wide analysis showed 
the HMNC1 gene had the 
strongest association with PND 
symptoms. 
The GA genotype of SNP 
rs2891230 was associated with 
PND. 
 
Mahon et al 2009 
Alvim-Soares et al 
2014 
ESR1 ESR1 TA Estrogens can act on multiple 
central nervous system pathways 
by binding to intracellular 
estrogen receptor encoded by 
ESR1and affecting transcription 
in target tissues and also through 
non-classical second messenger 
systems.  Estrogen can modulate 
serotonin transmission among 
several of these pathways.  
A sig association was reported 
between the upstream TA 
microsatellite repeat and EPDS 
scores (p=0.007) and the 
occurrences of PND. 
Pinsonneault et al 
2013 
OXT rs2740210 
 
 
 
rs4813627 
 
Maternal depression mediates the 
effects of early adversity on 
breastfeeding and these same 
OXT-related polymorphisms 
moderate this mediation.  
 
The effect of OXT genotype and 
early experiences will be 
mediated by postpartum maternal 
mood state. 
rs2740210 interacted with early 
life adversity and quality of care 
mothers experienced in early life 
to predict depression (CC) 
 
 
rs4813627 interacted with quality 
of care mothers experienced in 
early life to predict depression 
(G/G) 
Jonas et al 2013 
Mileva-Seitz et al 
2013 
 
Mileva-Seitz et al 
2013 
27 
 
Table 3 A summary of the suggested genetic and epigenetic mechanisms and results for the statistically significant 
associations reported within the included literature 
 
Table 3 summarises the associations reported in the literature and the mechanisms thought to 
underlie these associations in order to identify candidate genes and pathways that may be 
appropriate for future study.  
 
 
 
OXTR Methylation 
levels  
Estrogen variation induced by 
pregnancy and childbirth 
modulates the OXT system at the 
OXTR with estradiol increasing 
OXTR gene transcription. OXTR 
DNA methylation will be 
associated with PND at 
functionally relevant CpGs. 
Methylation levels at CpGs 
located on chr3 at positions 
8810078 and 8810069 exhibited 
sig association with PND. 
Moderate evidence was also 
shown for an interaction of CpGs 
in the region with child abuse to 
mediate PND. 
Kimmel et al 2016 
OXTR Genotype and 
methylation 
levels 
The combined effect of genotype 
and methylation level affects 
OXTR function.  
Women with the rs53576 GG 
genotype showed 2.63 greater 
odds of PND for every 10% 
increase in methylation level, 
whereas methylation was 
unrelated to PND amongst “A” 
carriers. This was only seen in 
women with postnatal onset of 
symptoms. 
Bell et al 2015 
HP1BP3 
&  
TTC9B 
Methylation 
patterns 
Changes in patterns of 
methylation at these two genes 
caused by childbirth related 
changes in estrogen levels 
predicts PND with some women 
being more sensitive to estrogen 
changes than others. 
Methylation levels at these two 
genes were able to predict PND in 
a cohort of women with a history 
of psychiatric illness with a high 
degree of accuracy (AUC 0.96) 
and with moderate success in a 
cohort of women both with and 
without a history of psychiatric 
illness (AUC 0.81).  
Guintivano et al 2013 
Osborne et al 2015 
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3. Quality of the evidence presented 
This area of research is relatively new and a large number of variants have been investigated 
with few large replication studies to date. In weighing the strength of the evidence for the 
associations reported, some methodological approaches and study designs within the included 
studies are worthy of note.  The reliability of associations reported in genetic studies is often 
questioned due to low sample size and therefore inadequate statistical power. Indeed, many of 
the studies assessed in this review did not clearly report on how sample size had been 
determined.  Nominally statistically significant results in underpowered studies have a low 
predictive value in reflecting real associations.  Therefore, associations reported in smaller, 
underpowered studies must be viewed with caution until they are replicated in a larger cohort. 
Further to this, several studies are utilizing data from the same population, possibly inflating 
the strength of  some findings (see table 1).  
 
A case-control study design was frequently used in the studies to ensure a comparative sample 
of depressed and healthy postnatal women, but these results cannot necessarily be extrapolated 
to represent the general population. Additional factors that limit generalisability include 
recruitment of single ethnicity (Mileva-Seitz et al 2013, Doornbos et al 2009, Gelabert et al 
2012, Engineer et al 2013, Tan et al 2015) and recruitment of women with a history of 
psychiatric illness.   
The tools used to measure PND were of good quality, with 14 studies using clinical assessment 
to formally diagnose PND.  The most common approach taken was to measure PND via a 
screening tool, however a number of different tools were used limiting comparability across 
the studies. The Edinburgh Postnatal Depression Scale was the most commonly used (N=20, 
54% of included studies); it detects the level of PND symptoms with a high degree of sensitivity 
and specificity.  However, variation in the time points at which depression was assessed 
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hampered synthesis of results.  Furthermore, 17 of the 37 studies did not assess maternal mood 
during pregnancy making it difficult to determine whether the depression was of postnatal or 
antenatal onset, or was pre-existing.  
 
The effect of environmental factors may be particularly pertinent in the case of PND. In 
addition to the changes in roles and the transition to becoming a parent, women experience the 
physical challenges of pregnancy and childbirth. However, only 11 of the 37 studies (30%) 
investigated gene-environment interaction which may account for some of the inconsistencies 
in results between studies. Within the studies that did assess environmental factors, various 
methods of measurement were used such as self-completion questionnaires or interviews. 
Where validated measures were used, psychometric information is given confirming their 
validity and reliability within the study populations.   
 
Studies incorporating environmental factors revealed associations where studies investigating 
genetic carrier status alone did not. For example, carrier status of BNDF Val66Met was 
associated with PND only when the mother delivered in winter or autumnal months (Comasco 
et al 2011).  In studies examining genotype alone, an interaction of the genetic variation with 
an environmental factor leading to increased risk for PND may have been missed. There has 
been little attempt to investigate gene to gene interactions within studies.  Gene expression and 
protein levels are also not generally measured and this may be considered a limitation,  as 
without these measures the functional consequences of genetic and epigenetic variability 
remain unknown. In a systematic review of the genetic variability in inflammatory markers to 
depression Barnes et al (2017) noted that mRNA gene-expression studies showed more reliable 
associations with outcomes than studies of genetic variants.  Changes in mRNA and protein 
levels can be the consequence of genetic or epigenetic variation and can elucidate mechanisms 
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and pathways that are involved in PND. Studies incorporating both genetic/epigenetic 
assessments in combination with gene expression data and even protein levels, therefore, may 
be considered the gold standard in trying to establish the mechanism underlying the 
associations with PND.  
Discussion 
This review synthesizes the current literature on the emerging association between genetic 
variants, epigenetic modifications and PND. Identification of potential genetic and epigenetic 
biomarkers may potentially enhance the accuracy of current predictive models, facilitating 
early intervention to improve outcomes for mothers and infants.  Although two large GWAS 
studies (N=10,893 and N=1,210,759) searching for genetic biomarkers for PND, have had 
limited success in eliciting specific biomarkers, this could be explained by the polygenetic 
nature of depression and the role that environmental factors play in its onset.  The importance 
of environmental factors has been demonstrated in studies showing associations between PND 
and 5HTT carrier status in the presence of stressful life events, BDNF Met carrier status during 
autumnal and winter months and OXT and OXTR carrier status in the presence of childhood 
adversity experienced by the mother.   
  
The associations reported in this review and summarized in Table 3 suggest that the unique 
physiological changes brought about by the body’s adaptation to pregnancy and childbirth 
may influence the effect of genetic variants, and can lead to epigenetic changes  that increase  
risk of PND. The reviews by Figueiredo et al. (2015) on depression in the perinatal period 
and by McEvoy et al. (2017) on premenstrual dysphoric disorder and postnatal depression 
support our findings that genetic and epigenetic studies reinforce support the hypothesis that 
hormonal change and estrogen signaling during childbirth can lead to epigenetic changes  
associated with increased risk of depression.  
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Limited associations between biological processes that have been implicated in depression at 
other life stages were found in association with PND.  For example, associations between 
SNPs that impact the function of the HPA axis and PND were not found to be strong, 
possibly because of the dampening down of this system during pregnancy (Brunton et al 
2008). 
 
PND experienced by women with a history of depression may also be linked to different 
underlying biological processes, and therefore a different group of biomarkers, than PND in 
women with no psychiatric history.  For example, the ‘S’ allele of the 5-HTTPLR was 
associated with PND specifically in women with a previous history of psychiatric illness.  
 
Mitchel et al (2011) suggested that genetic carrier status in the 5-HTTPLR may confer a 
biological sensitivity to context, theorising that the S allele and the 10 allele of a tandem repeat 
polymorphism (STin2 VNTR in intron 2 of the SLC6A4 gene), rather than conferring risk, 
heightened women’s sensitivity to their environment.  They reported these alleles as positively 
associating with PND in an unfavourable environment and negatively associating in a 
favourable environment. This bi-directional outcome may explain some of the inconsistencies 
in the results from the studies investigating the 5-HTTLPR, but further studies are needed to 
investigate this further.  
 
Limitations of this review 
Although 37 papers were identified for inclusion, there were only a small number of papers 
investigating each polymorphism or epigenetic marker making it difficult to draw firm 
conclusions, especially if study results were inconsistent. This literature review has searched 
for original research from peer-reviewed journals and therefore does not include grey literature.  
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This may mean that further relevant studies that would have met the quality standards for 
inclusion have been omitted.    
 
Conclusion 
Based on the reviewed evidence, the risk for PND is unlikely to be defined by a woman’s 
genetic profile alone.  Environmental influences interact with and mediate the effect of 
genetic carrier status and are important in determining the overall risk of developing PND; 
potentially through epigenetic mechanisms. A framework based on genetic variants, 
epigenetic modification and environmental factors may generate useful predictive models that 
could assist in identifying women who have an elevated risk of PND.   
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